TRUH vs. CNCR
TRUH (VanEck Healthcare TruSector ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds.
Performance
TRUH vs. CNCR - Performance Comparison
Loading charts...
Returns By Period
TRUH
- 1D
- -1.18%
- 1M
- 6.79%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
TRUH vs. CNCR - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
TRUH VanEck Healthcare TruSector ETF | 8.59% |
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRUH vs. CNCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Healthcare TruSector ETF (TRUH) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Drawdowns
TRUH vs. CNCR - Drawdown Comparison
The maximum TRUH drawdown since its inception was -4.51%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for TRUH and CNCR.
Loading charts...
Drawdown Indicators
| TRUH | CNCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -4.51% | 0.00% | -4.51% |
Current DrawdownCurrent decline from peak | -3.25% | 0.00% | -3.25% |
Average DrawdownAverage peak-to-trough decline | -1.63% | 0.00% | -1.63% |
Volatility
TRUH vs. CNCR - Volatility Comparison
Loading charts...
Volatility by Period
| TRUH | CNCR | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 17.58% | 0.00% | +17.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.58% | 0.00% | +17.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.58% | 0.00% | +17.58% |
Dividends
TRUH vs. CNCR - Dividend Comparison
TRUH's dividend yield for the trailing twelve months is around 0.31%, while CNCR has not paid dividends to shareholders.
| Position | TTM |
|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
TRUH VanEck Healthcare TruSector ETF | 0.31% |
Frequently Asked Questions
TRUH has the higher dividend yield at 0.31%, compared with 0.00% for CNCR.
They also come from different issuers: VanEck and Exchange Traded Concepts.
Find the right allocation for TRUH and CNCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer